Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reply to E.A. Rakha et al.

Literature DB >> 25753441

Reply to E.A. Rakha et al.

Antonio C Wolff¹, M Elizabeth H Hammond², David G Hicks³, Kimberly H Allison⁴, John M S Bartlett⁵, Michael Bilous⁶, Patrick Fitzgibbons⁷, Wedad Hanna⁸, Robert B Jenkins⁹, Pamela B Mangu¹⁰, Soonmyung Paik¹¹, Edith A Perez¹², Michael F Press¹³, Patricia A Spears¹⁴, Gail H Vance¹⁵, Giuseppe Viale¹⁶, Mitch Dowsett¹⁷, Lisa M McShane¹⁸, Daniel F Hayes¹⁹.

Abstract

Mesh：

Substances：

Year: 2015 PMID： 25753441 DOI： 10.1200/JCO.2014.59.7559

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Long term side effects of adjuvant chemotherapy in patients with early breast cancer.

Authors: Jessica J Tao; Kala Visvanathan; Antonio C Wolff
Journal: Breast Date: 2015-08-20 Impact factor: 4.380

2. HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features.

Authors: Rachel L Stewart; Justin E Caron; Evin H Gulbahce; Rachel E Factor; Katherine B Geiersbach; Erinn Downs-Kelly
Journal: Mod Pathol Date: 2017-07-28 Impact factor: 7.842

3. [Update of the German S3 breast cancer guideline : What is new for pathologists?]

Authors: A Lebeau; C Denkert; P Sinn; M Schmidt; A Wöckel
Journal: Pathologe Date: 2019-03 Impact factor: 1.011

4. Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.

Authors: Hyun-Seok Kim; Christopher B Umbricht; Peter B Illei; Ashley Cimino-Mathews; Soonweng Cho; Nivedita Chowdhury; Maria Cristina Figueroa-Magalhaes; Catherine Pesce; Stacie C Jeter; Charles Mylander; Martin Rosman; Lorraine Tafra; Bradley M Turner; David G Hicks; Tyler A Jensen; Dylan V Miller; Deborah K Armstrong; Roisin M Connolly; John H Fetting; Robert S Miller; Ben Ho Park; Vered Stearns; Kala Visvanathan; Antonio C Wolff; Leslie Cope
Journal: J Clin Oncol Date: 2016-10-31 Impact factor: 44.544

5. New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.

Authors: N Tchrakian; L Flanagan; J Harford; J M Gannon; C M Quinn
Journal: Virchows Arch Date: 2015-10-31 Impact factor: 4.064

Reply to E.A. Rakha et al.

Review 1. Long term side effects of adjuvant chemotherapy in patients with early breast cancer.

2. HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features.

3. [Update of the German S3 breast cancer guideline : What is new for pathologists?]

4. Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.

5. New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.

6. Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience.

7. EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.

Review 8. HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation.